Mark W Hahn Verona Pharma PLC (VRNA) insider trading activity

Mark W Hahn is Chief Financial Officer of Verona Pharma plc. Currently has a direct ownership of 12.4 Million shares of VRNA, which is worth approximately $1.12 Billion. The most recent transaction as insider was on Jul 08, 2025, when has been sold 90,320 shares (Ordinary Shares) at a price of $11.44 per share, resulting in proceeds of $1,033,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4M

6.82% 3M change

16.9% 12M change

Total Value Held $1.12 Billion

Mark W Hahn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 08 2025	SELL Payment of exercise price or tax liability	$1,033,260 $11.44 p/Share	90,320 Reduced 0.72%	12,418,184 Ordinary Shares
Jul 07 2025	BUY Exercise of conversion of derivative security	-	229,512 Added 1.8%	12,508,504 Ordinary Shares
Jun 11 2025	SELL Open market or private sale	$4,560,000 $11.4 p/Share	400,000 Reduced 3.15%	12,278,992 Ordinary Shares
May 29 2025	SELL Open market or private sale	$1,911,381 $9.33 p/Share	204,864 Reduced 1.59%	12,678,992 Ordinary Shares
May 28 2025	SELL Open market or private sale	$1,513,147 $9.3 p/Share	162,704 Reduced 1.25%	12,883,856 Ordinary Shares
May 27 2025	SELL Open market or private sale	$309,076 $9.53 p/Share	32,432 Reduced 0.25%	13,046,560 Ordinary Shares
May 02 2025	SELL Open market or private sale	$3,636,000 $9.09 p/Share	400,000 Reduced 2.97%	13,078,992 Ordinary Shares
May 01 2025	SELL Open market or private sale	$1,673,721 $8.95 p/Share	187,008 Reduced 1.37%	13,478,992 Ordinary Shares
May 01 2025	BUY Exercise of conversion of derivative security	-	200,000 Added 1.45%	13,557,728 Ordinary Shares
Apr 29 2025	SELL Open market or private sale	$811,432 $8.98 p/Share	90,360 Reduced 0.67%	13,466,000 Ordinary Shares
Apr 29 2025	BUY Exercise of conversion of derivative security	-	229,512 Added 1.66%	13,556,360 Ordinary Shares
Feb 03 2025	SELL Payment of exercise price or tax liability	$1,194,918 $7.16 p/Share	166,888 Reduced 1.24%	13,326,848 Ordinary Shares
Feb 01 2025	BUY Grant, award, or other acquisition	-	200,000 Added 1.46%	13,493,736 Ordinary Shares
Dec 06 2024	SELL Open market or private sale	$920,477 $5.01 p/Share	183,728 Reduced 1.36%	13,293,736 Ordinary Shares
Dec 05 2024	SELL Open market or private sale	$3,206,640 $5.01 p/Share	640,048 Reduced 4.53%	13,477,464 Ordinary Shares
Dec 04 2024	SELL Open market or private sale	$290,920 $5.0 p/Share	58,184 Reduced 0.41%	14,117,512 Ordinary Shares
Dec 02 2024	SELL Open market or private sale	$8,000 $5.0 p/Share	1,600 Reduced 0.01%	14,175,696 Ordinary Shares
Nov 29 2024	SELL Open market or private sale	$494,507 $5.01 p/Share	98,704 Reduced 0.69%	14,177,296 Ordinary Shares
Nov 27 2024	SELL Open market or private sale	$64,680 $5.0 p/Share	12,936 Reduced 0.09%	14,276,000 Ordinary Shares
Nov 26 2024	SELL Open market or private sale	$4,000 $5.0 p/Share	800 Reduced 0.01%	14,288,936 Ordinary Shares
Nov 25 2024	SELL Open market or private sale	$8,000 $5.0 p/Share	1,600 Reduced 0.01%	14,289,736 Ordinary Shares
Nov 11 2024	SELL Open market or private sale	$12,000 $5.0 p/Share	2,400 Reduced 0.02%	14,291,336 Ordinary Shares
Nov 04 2024	SELL Open market or private sale	$354,641 $4.39 p/Share	80,784 Reduced 0.56%	14,293,736 Ordinary Shares
Nov 01 2024	SELL Open market or private sale	$214,129 $4.38 p/Share	48,888 Reduced 0.34%	14,374,520 Ordinary Shares
Nov 01 2024	SELL Payment of exercise price or tax liability	$1,042,836 $4.24 p/Share	245,952 Reduced 1.68%	14,423,408 Ordinary Shares

MWH

Mark W Hahn

Chief Financial Officer

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verona Pharma plc

Track Activities on VRNA

Account